A collaborative research team from the UK and Switzerland has successfully developed the world's inaugural genetically uniform human 'lung-on-a-chip' model. This innovative chip leverages stem cells sourced from a single donor to precisely mimic the breathing dynamics and infection responses of individual alveoli, paving the way for tailored treatments for respiratory ailments. Prior to this breakthrough, lung-on-a-chip models faced challenges in fully replicating the lung function and disease progression specific to an individual. The novel chip reconstructs the alveolar barrier architecture through advanced laboratory techniques, simulates breathing with a specialized apparatus, and introduces macrophages along with Mycobacterium tuberculosis. This setup vividly portrays the pathological features of early-stage infection, offering a holistic view for comprehending disease progression.